Value of PAM50 risk of recurrence score in patients with HR positive HER2 negative early breast cancer and intermediate risk: A single cancer center institution prospective observational study

被引：0
|
作者：
Nicolai, Vincent [1 ]
Gilhodes, Julia [1 ]
Lacaze, Jean Louis [1 ]
Ung, Mony [1 ]
De Maio, Eleonora [1 ]
Duprez-Paumier, Raphaelle [1 ]
Vaysse, Charlotte [1 ]
Filleron, Thomas [1 ]
Jouve, Eva [1 ]
Selmes, Gabrielles [1 ]
Franchet, Camille [1 ]
Massabeau, Carole [1 ]
Chira, Cyprian [1 ]
Izar, Francoise [1 ]
Roche, Henri [1 ]
Pradines, Anne [1 ]
Dalenc, Florence [1 ]
机构：
[1] IUCT O, Toulouse, France
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P2-18-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-18-06
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
    Lien, Tonje
    Ohnstad, Hege Oma
    Lingjaerde, Ole Christian
    Vallon-Christersson, Johan
    Aaserud, Marit
    Sveli, My Anh Tu
    Borg, Ake
    OSBREAC, Oystein
    Garred, Oystein
    Borgen, Elin
    Naume, Bjorn
    Russnes, Hege
    Sorlie, Therese
    CANCERS, 2021, 13 (23)
  • [2] PAM50MET: A prognostic model based on PAM50 and clinical variables in metastatic hormone receptor (HR)-positive/HER2 negative breast cancer
    Prat, A.
    Tsai, Y. -H.
    Pascual, T.
    Pare, L.
    Vidal, M.
    Adamo, B.
    Brase, J. C.
    Johnston, S. R. D.
    Ciruelos, E. M.
    Parker, J. S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study
    Boitumelo Phakathi
    Therese Dix-Peek
    Eunice Van Den Berg
    Caroline Dickens
    Sarah Nietz
    Herbert Cubasch
    Maureen Joffe
    Alfred I. Neugut
    Judith S. Jacobson
    Paul Ruff
    Raquel Duarte
    Breast Cancer Research and Treatment, 2023, 200 : 337 - 346
  • [4] Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
    Ohnstad, Hege O.
    Borgen, Elin
    Falk, Ragnhild S.
    Lien, Tonje G.
    Aaserud, Marit
    Sveli, My Anh T.
    Kyte, Jon A.
    Kristensen, Vessela N.
    Geitvik, Gry A.
    Schlichting, Ellen
    Wist, Erik A.
    Sorlie, Therese
    Russnes, Hege G.
    Naume, Bjorn
    BREAST CANCER RESEARCH, 2017, 19
  • [5] Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
    Hege O. Ohnstad
    Elin Borgen
    Ragnhild S. Falk
    Tonje G. Lien
    Marit Aaserud
    My Anh T. Sveli
    Jon A. Kyte
    Vessela N. Kristensen
    Gry A. Geitvik
    Ellen Schlichting
    Erik A. Wist
    Therese Sørlie
    Hege G. Russnes
    Bjørn Naume
    Breast Cancer Research, 19
  • [6] PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study
    Phakathi, Boitumelo
    Dix-Peek, Therese
    van den Berg, Eunice
    Dickens, Caroline
    Nietz, Sarah
    Cubasch, Herbert
    Joffe, Maureen
    Neugut, Alfred I.
    Jacobson, Judith S.
    Ruff, Paul
    Duarte, Raquel
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (03) : 337 - 346
  • [7] Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review
    Canino, Fabio
    Piacentini, Federico
    Omarini, Claudia
    Toss, Angela
    Barbolini, Monica
    Vici, Patrizia
    Dominici, Massimo
    Moscetti, Luca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [8] Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
    Fernandez-Martinez, Aranzazu
    Pascual, Tomas
    Perrone, Giuseppe
    Morales, Serafin
    de la Haba, Juan
    Gonzalez-Rivera, Milagros
    Galvan, Patricia
    Zalfa, Francesca
    Amato, Michela
    Gonzalez, Lucia
    Prats, Miquel
    Rojo, Federico
    Manso, Luis
    Pare, Laia
    Alonso, Immaculada
    Albanell, Joan
    Vivancos, Ana
    Gonzalez, Antonio
    Matito, Judit
    Gonzalez, Sonia
    Fernandez, Pedro
    Adamo, Barbara
    Munoz, Montserrat
    Viladot, Margarita
    Font, Carme
    Aya, Francisco
    Vidal, Maria
    Caballero, Rosalia
    Carrasco, Eva
    Altomare, Vittorio
    Tonini, Giuseppe
    Prat, Aleix
    Martin, Miguel
    ONCOTARGET, 2017, 8 (13) : 21930 - 21937
  • [9] Identification of Patients with Early HR+HER2-Breast Cancer at High Risk of Recurrence
    Fasching, Peter A.
    Kreipe, Hans
    Del Mastro, Lucia
    Ciruelos, Eva
    Freye, Gilles
    Korfe, Agnieszka
    Chouaki, Nadia
    Stoffregen, Clemens
    Sapunar, Francisco
    Camero, David
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (02) : 164 - 184
  • [10] Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India
    Parikh, Purvish M.
    Bhattacharyya, Gouri Shankar
    Biswas, Ghanshyam
    Krishnamurty, Arvind
    Doval, Dinesh
    Heroor, Anil
    Sharma, Sanjay
    Deshpande, Ramakant
    Chaturvedi, Harit
    Somashekhar, S. P.
    Babu, Govind
    Reddy, G. Krishna
    Sarkar, Diptendra
    Desai, Chirag
    Malhotra, Hemant
    Rohagi, Nitesh
    Bapna, Ajay
    Alurkar, S. S.
    Krishna, Prasad
    Deo, S. V. S.
    Shrivastava, Anurag
    Chitalkar, Prakash
    Majumdar, Saroj Kumar
    Vijay, Devanhalli
    Thoke, Aniket
    Udupa, K. S.
    Bajpai, Jyoti
    Rath, G. K.
    Dattatreya, Palanki Satya
    Bondarde, Shailesh
    Patil, Shekhar
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (04) : 213 - 219
12345